Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Translational Oncology|February 22, 2025
Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogrammingYu Li, Yifan Jiang, Rongliang Tong, et al.
Frontiers in Oncology|May 6, 2021
Apolipoprotein B Is Associated With the Microenvironment of CholangiocarcinomaXiaofeng Xu, Diyu Chen, Xiaode Feng, et al.
Cell Death & Disease|February 22, 2023
PAK2 is essential for chromosome alignment in metaphase I oocytesJuan Zeng, Shiwei Wang, Min Gao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 22, 2019
Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosisLongfei Dai, Wendi Hu, Zhenjie Yang, et al.
International Journal of Biological Sciences|November 17, 2018
The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis inductionBin He, Longfei Dai, Xiaoqian Zhang, et al.
Signal Transduction and Targeted Therapy|August 27, 2025
Transforming acidic coiled-coil-containing protein 3-mediated lipid metabolism reprogramming impairs CD8+ T-cell cytotoxicity in hepatocellular carcinomaYing Li, Zule Chen, Dongdong Wang, et al.
International Journal of Oncology|March 14, 2018
H2A.Z regulates tumorigenesis, metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinomaBeng Yang, Rongliang Tong, Hua Liu, et al.
Journal of Cellular and Molecular Medicine|October 22, 2019
Efficient gene correction of an aberrant splice site in β-thalassaemia iPSCs by CRISPR/Cas9 and single-strand oligodeoxynucleotidesZeyu Xiong, Yingjun Xie, Yi Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 30, 2023
Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune EvasionDeguo Zhang, Da Man, Jiahua Lu, et al.
Hepatology (Baltimore, Md.)|November 7, 2025
GPC3-based circular RNA vaccine suppresses hepatocellular carcinoma progression by activating adaptive immune responsesYifan Jiang, Yu Li, Tong Wu, et al.
Pageof 6